Moreover, ampelopsin, also known as dihydromyricetin, inhibited stem cell properties (colony formation, mammosphere formation, CD44+/CD24-/low populations, aldehyde dehydrogenase (ALDH) activity, and other stem cell markers such as reduced p-IκBα accompanied by suppressed NF-κB p65 among others in resistant BC cells (MDA-MB-231/IR) [183]. The gene discussed is NFKB1; the disease is breast cancer.